baber/WOPTO huggingface dataset:
Patent CA-2483484-A1 (CA)
Title: Interchangeable eyewear assembly
Inventor: TOSHIRO FUJIUCHI
IPC: C03C4/00
Filed: 2004-10-01
Abstract: An eyewear system enables a person to switch lenses among a variety of frames or switch a variety of lenses within a single frame. The lenses are positioned in one or more subframe assemblies that can be easily attached to and detached from a frame assembly that may not otherwise contain lenses.
Patent CA-2484433-A1 (CA)
Inventor: BAUER TIM
IPC: B32B27/10
Filed: 2004-10-08
Abstract: A laminated medical examination paper for use in a doctor's office or other medical or health care delivery setting.
Patent CA-2487521-A1 (CA)
Inventor: HENDERSON JACK V
IPC: B60J1/08
Filed: 2004-11-09
Abstract: A door assembly with upper and lower door portions.      The upper door portion has a window section with one or more clear panels mounted in a frame member. In use, the entire upper door portion including the frame member and window section can be removed as a unit and conveniently stored in a pocket or cavity in the lower door portion.      The window section in one embodiment has a vertically retractable panel and in another, two clear panels are provided that can be slid horizontally to open the window area. Another embodiment has a folding or pivoting upper door portion which can be collapsed on itself and conveniently stored in the cavity or pocket of the lower door portion.
Patent CA-2487692-A1 (CA)
Inventor: GRIFFITHS GARY L
IPC: A61K39/395
Filed: 2003-05-28
Abstract: A method for treating a brain tumor by administering to a patient (i) a multispecific antibody comprising at least one targeting arm that binds to a brain cancer antigen and at least one capture arm that binds to a radionucli de carrier; (ii) a therapeutic radionuclide carrier to which is bound a therapeutic radionuclide, wherein the multispecific antibody, radionuclide carrier and therapeutic radionuclide are administered in a substantially equimolar ratio.
Patent CA-2489227-A1 (CA)
Inventor: TAKASU HIDEO
IPC: A61K35/76
Filed: 2003-06-12
Abstract: HLA-A24-restricted peptides derived from WT1 which have an activity to induce CTLs in vivo, polynucleotides encoding said peptides, cancer vaccines using those peptides or polynucleotides in vivo or in vitro, or the like are provided. The cancer vaccines of the present invention may be used to treat many cancer patients.
Patent CA-2492843-A1 (CA)
Title: Post-termination contact management
Inventor: HEMM THOMAS L
IPC: H04L12/28
Filed: 2005-01-17
Abstract: The present invention is directed to a method for servicing a transaction in a contact center. When a communication associated with a transaction is terminated prematurely, special treatment may be provided to the transaction initiator. The special treatment includes: (a) maintaining, relative to other transactions, the assigned service priority for the transaction while the communication is disconnected and assigning the assigned service priority to a subsequent inbound communication from the transaction initiator;  (b) scheduling a subsequent outbound communication to an external endpoint associated with the transaction initiator; (c) assigning to the transaction initiator a favored service priority when the subsequent inbound communication is received by the contact center; and (d) when, during the first communication, the transaction initiator selected at least one item as part of an electronic order and the first communication was terminated before the electronic order was completed, maintaining the item(s) in memory and providing the item(s) to the transaction initiator when the transaction initiator makes a further communication with the contact center.
Patent CA-2494054-A1 (CA)
Title: Composite sling and sling assembly tool for treating incontinence
Inventor: BACHMAN TIMOTHY A
IPC: A61B19/00
Filed: 2003-08-04
Abstract: Surgical articles, implants and components suitable creating composite sling s are described. Novel procedures for assembling and utilizing composite sling s are also detailed.
Patent CA-2496067-A1 (CA)
Title: Data compression
Inventor: KADATCH ANDREW V
IPC: H03M7/30
Filed: 2005-02-03
Abstract: Compression of streaming data is described. In an implementation, a method includes compressing data for communication in a terminal services environment by finding an index in a lookup table that matches an initial sequence in data.  The lookup table includes a plurality of entries. Each of the entries is discoverable utilizing a particular one of a plurality of the indices. Each entry references whether a corresponding index is located in a history buffer, and if so, further references one or more locations of the corresponding index in the history buffer. If the corresponding entry of the matching index references a plurality of locations, for each location, a sequence having the matching index is compared with a sequence in the data that includes the initial sequence. A matching sequence is derived from the comparison based on a length and the location of the sequence at each of the locations. The matching sequence is represented using a representation that includes the length and the location of the matching sequence in the history buffer.
Patent CA-2496125-A1 (CA)
Title: Flexible integrated photovoltaic roofing membrane and related methods of manufacturing same
Inventor: MAYTUBBY C DANIEL
IPC: H01L31/042
Filed: 2005-02-08
Abstract: Disclosed herein are flexible, solar powered photovoltaic (PV) integrated roofing membrane and related methods of manufacturing such a membrane. The disclosed membrane and methods beneficially provide solar power to structures in either off grid or on-grid connections. The roofing membrane may comprise multiple membrane strips or members having electrically interconnected photovoltaic solar elements. The membrane members preferably have distinct patterns for the solar elements located thereon that provide for coverage of entire sections, upon installation, as well as accommodate interconnections between the solar elements. Moreover, the membrane will appreciate the numerous types of patterns to achieve such purposed of full coverage and electrical coupling.
Patent CA-2497715-A1 (CA)
Inventor: CULLEN DOUGLAS WILSON
IPC: F16M1/00
Filed: 2005-02-18
Abstract: A device 60 for fixing together first and second side-by-side beams of a kind having first and second spaced apart flanges connected by a web. The device 60 comprises a member 62 having first and second opposing ends 64, 66 and is configured to extend from a first flange to a second flange of the beams. The device further comprises at least one portion 68, 70 extending laterally of each of said first and second opposing ands with the at least one portion at the first opposing end being configured to be fixed to an outer surface of the first flange of the first beam and the at least one portion at the second opposing end being configured to be fixed to an outer surface of the second flange of the second beam.
Patent CA-2497910-A1 (CA)
Title: Coolant solutions and compositions comprising the same
Inventor: MORAES EDUARDO
IPC: A61Q19/00
Filed: 2003-10-27
Abstract: A solution consisting essentially of menthyl lactate and menthol carboxamide dissolved in a solvent, such as propylene glycol, which solvent is acceptabl e for food, oral care or cosmetic products and a method of preparing it.</SDOA B>
Patent CA-2498890-A1 (CA)
Inventor: BONNY JEAN-DANIEL
IPC: A61K9/28
Filed: 2003-09-19
Abstract: Oral once a day dosage forms comprising oxcarbazepine are disclosed.
Patent CA-2500918-A1 (CA)
Title: Powder metal clutch races for one-way clutches and method of manufacture
Inventor: NIGARURA SALVATOR
IPC: B22F5/08
Filed: 2003-06-30
Abstract: A method of fabricating clutch races for one-way clutch mechanis ms includes compacting and sintering a ferrous-based powder metal to near-net shape to produce a core density of between about 6.8 to 7.6 g/cc and a race surface that is near-net shape. The cam surface is cold worked in a manner that locally increases the density at the surface to develop a highly densified layer of essentially fully densified material and with a final surface finish that, after heat treatment, is ready to use in a one-way clutch application without further working. Both the inner and outer clutch races of one-way clutch mechanisms can be formed in this fashion and yield races that exhibit excellent strength, toughness, fatigue strength and wear resistance.
Patent CA-2502234-A1 (CA)
Inventor: JAQUESS PERCY A
IPC: A01N43/36
Filed: 2003-10-15
Abstract: L'invention concerne une composition biocide comprenant une N-bromo-2-pyrrolidone stable. L'invention concerne également une autre composition obtenue par réaction d'un acide hypobromeux avec la 2-pyrrolidone, ainsi que des utilisations biocides.
Patent CA-2502459-A1 (CA)
Inventor: MULLET WILLIS J
IPC: E06B3/48
Filed: 2003-09-29
Abstract: A sectional door D having a plurality of panels (35), a first hinge leaf (44 ) formed on one edge of a panel and a second hinge leaf (42) formed on a secon d edge of the panel, wherein first and second hinge leaves on adjacent panels interrelate to form a hinge pivotally joining the panels, and a strengthenin g member (50) having a body portion (51) adapted to capture the hinge leaves a nd attachable to the panels near at least one of the first hinge leaf and the second hinge leaf.
Patent CA-2502595-A1 (CA)
Inventor: ONNEBY CARINA
IPC: C08K3/14
Filed: 2003-10-20
Abstract: La présente invention porte sur un matériau de transformation d'un champ électrique qui comprend une matrice polymère pourvue d'une charge. La charge comprend une quantité effective de particules pour la transformation du champ, la dimension des particules étant au moins inférieure ou égale à 100 nm. L'invention porte également sur un dispositif comprenant ce matériau de transformation de champ qui permet de transformer un champ électrique dans des applications haute tension, et sur un procédé de transformation d'un champ électrique au niveau d'un raccordement ou d'une extrémité d'un câble électrique constitué de ce matériau de transformation de champ.
Patent CA-2504524-A1 (CA)
Inventor: LITVACK FRANK
IPC: A61F2/00
Filed: 2003-11-10
Abstract: Methods and apparatus for treatment of vulnerable plaque provide local delivery of one or more plaque stabilizing agents. Delivery of the plaque stabilizing agents described herein stabilize vulnerable plaques at and downstream of an implantation site can reduce the occurrence of rupture of these plaques. An expandable medical device for delivering a therapeutic agent locally to a vulnerable plaque includes an implantable medical device body configured to be implanted within a coronary artery, and a therapeutic dosage of a therapeutic agent for stabilization of vulnerable plaque. The therapeutic agent is affixed in openings in the implantable medical device body in a manner such that the therapeutic agent is released to the vulnerable plaque at a therapeutic dosage and over an administration period effective to stabilize the vulnerable plaque.
Patent CA-2504551-A1 (CA)
Inventor: GLAENZER KLAUS
IPC: A61K9/20
Filed: 2005-04-12
Abstract: Method for preparing a valsartan (I; (S)-N-(1-carboxy-2-methylprop-1yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]amine) adsorabte and/or its solvate or hydrate. Method for preparing a valsartan (I; (S)-N-(1-carboxy-2-methylprop-1yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]amine) adsorbate and/or its solvate or hydrate comprises suspending at least one adsorber material (A) in a solution, in organic solvent, of (I) or its salt and/or solavate or hydrate, then removing solvent. The solution has total water content not over 15, particularly 5, wt.% and (A) is any of cellulose (or derivatives); polyols; sugars (or derivatives); malto- or cyclo-dextrins; starch and/or polydextrose. An independent claim is also included for valsartan adsorbate, and solvates, prepared by the new method. ACTIVITY : Hypotensive; Cardiant; Nephrotropic; Vasotropic; Antiarteriosclerotic; Antidiabetic; Antilipemic; Ophthalmological. No details of tests for these activities are given. MECHANISM OF ACTION : (I) is an antagonist of the angiotensin-II receptor with high selectivity for AT1 receptors.
Patent CA-2510901-A1 (CA)
Title: Indicator on body fluid absorbent article
Inventor: TAKAI HISASHI
IPC: A61F5/44
Filed: 2003-12-22
Abstract: An indicator (18) interposed between a liquid-impervious sheet (3) and an absorbent core (4) of a body fluid absorbent article includes a water-absorbent sheet (21) and indication elements (19) held in close contact with the water-absorbent sheet (21). The water-absorbent sheet (21) is preferably formed from porous thermoplastic films having a total luminous transmittance of 40 % or lower in a dry state and 60 % or higher in a wet state.
Patent CA-2513751-A1 (CA)
Title: Sustained release device and method for ocular delivery of adrenergic agents
Inventor: ASHTON PAUL
IPC: A61K9/22
Filed: 2004-01-23
Abstract: The invention provides a device and method for treating and/or preventing raised intraocular pressure, such as that associated with glaucoma or the use of corticosteroids with adrenergic agents. The invention provides insertable sustained-release devices adapted to maintain a therapeutically effective concentration of one or more adrenergic agents for an extended period of time, and a method of use thereof.
Patent CA-2513774-A1 (CA)
Title: Endoscopic tissue apposition device and method of use
Inventor: FOGEL ROBERTO
IPC: A61B17/062
Filed: 2005-07-26
Abstract: An endoscopic tissue apposition device that includes a vacuum chamber configured to securely hold a portion of tissue therein, the vacuum chamber being defined by a proximal wall and a distal wall opposite to the proximal wall.      Working and vacuum channels are provided in communication with the vacuum chamber. A portion of tissue is held in the vacuum chamber when vacuum is applied in the vacuum chamber through the vacuum channel. A carrier needle is disposed on a proximal side of the vacuum chamber and is longitudinally advanceable into and across the vacuum chamber, while a punch needle is disposed on a distal side of the vacuum chamber and is configured to receive the carrier needle therein. A hold and release mechanism holds and releases the punch needle to facilitate joining portions of tissue together.
Patent CA-2514102-A1 (CA)
Inventor: PEPIN MARYO
IPC: A01M31/00
Filed: 2005-08-12
Abstract: An animal call for use by a user. The call includes a call producing portion including a resonance cavity and a reed operatively coupled to the resonance cavity to convert vibrations of the reed into sound waves. The resonance cavity has first and second ends. A mouthpiece is connected to the first end of the resonance cavity. The mouthpiece receives air from the user and channels the air onto the reed to create the vibration therein. A megaphone is connected to the second end of the resonance cavity and amplifies sound waves produced within the call producing portion.
Patent CA-2515041-A1 (CA)
Inventor: CATALA JEAN-MARIE
IPC: C08F12/12
Filed: 2004-03-29
Abstract: The invention relates to a process for the preparation of poly(alpha-methylstyrene) by anionic polymerization of the alpha-methylstyrene monomer, said process successively comprising the following stages: a) a stage of preparation of a solution comprising the alpha-methylstyrene monomer and a nonpolar aprotic solvent; b) a stage of neutralization of the solution prepared in a) comprising the addition, to this solution, of an effective amount of at least one monofunctional organometallic initiator, so as to neutralize the proton sources of the solution prepared in a); c) a stage of cooling the solution obtained in b) to a temperature of less than 0° C.; d) a stage of initiation of the polymerization comprising the addition, to the cooled solution in c), of a predetermined amount of said monofunctional initiator; e) a stage of propagation of the polymerization comprising the addition, to the solution obtained in d), of a polar aprotic solvent, said solvent being added in an amount which is lower than that of the nonpolar aprotic solvent; f) a stage of termination comprising the addition, to the solution prepared in e), of a polar protic solvent.
Patent CA-2515888-A1 (CA)
Title: Self stowing thrust reverser
Inventor: LAIR JEAN-PIERRE
IPC: F02K1/70
Filed: 2004-02-19
Abstract: A thrust reverser (36) includes forward and aft louvers (54, 56) pivotally mounted in a compartment (50) defining a flow tunnel (52) through the outer and inner skins (38, 40) of a fan nacelle (16). An aft flap (60) is integrally joined to the aft louver (56) for rotation therewith. A unison link (64) joins together the forward and aft louvers (54, 56). And, an actuator (66) is joined to the louvers for rotation thereof between a stowed position in which the louvers and flap are closed in the nacelle skins and a deployed position in which the louvers and flap are pivoted open from the skins.
Patent CA-2515914-A1 (CA)
Inventor: GOLUNSKI STANISLAW EDMUND
IPC: C07C2/86
Filed: 2004-02-18
Abstract: A process for producing para-xylene by the selective methylation of toluene comprising contacting a reactant mixture comprising toluene, methanol and added water, with an oxide modified ZSM-5 zeolite catalyst in a flow reactor in conditions selected to limit coke formation on the catalyst and at a contact time, between reactant mixture and catalyst, of less than 1 second.
Patent CA-2518052-A1 (CA)
Inventor: DUPUIS DOMINIQUE
IPC: C08L19/00
Filed: 2004-03-08
Abstract: La présente invention concerne un procédé de préparation d'un liant bitumine ux ainsi que le liant bitumineux susceptible d'être obtenu par le procédé. Le procédé de préparation du liant bitumineux comprend une étape de mélange de 0,05 à 5% en poids d'acide, de 0,5 à 25% en poids de poudrettes de caoutchou c et de 70 à 99,5% en poids de bitume. La présente invention concerne égalemen t les bétons bitumineux comprenant ce liant, leur procédé de préparation et le ur utilisation.
Patent CA-2519112-A1 (CA)
Title: Optimized expression of hpv 31 l1 in yeast
Inventor: MARKUS HENRY Z
IPC: A61K31/675
Filed: 2004-03-19
Abstract: Synthetic DNA molecules encoding the HPV31 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV31 L1 protein, wherein said polynucleotides are free from internal transcription termination signals that are recognized by yeast. Also provided are syntheti c polynucleotides encoding HPV31 L1 wherein the polynucleotides have been codo n- optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV31 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV31 VLPs. The vaccines of the present invention provide effective immunoprophylaxis agains t papillomavirus infection through neutralizing antibody and cell-mediated immunity.
Patent CA-2520092-A1 (CA)
Inventor: LIN ZUEI-LING
IPC: E02D27/38
Filed: 2005-09-19
Abstract: An underwater oil storage method, which includes the steps of: a) excavating a cellar in the ground earth (10) and constructing a wall structure (20) in the cellar to form a water pool (30), b) setting an oil tank (40) in the water pool (30), c) supplying a predetermined amount of water to the water pool (30), and d) filling the oil to be stored into the oil tank (40) and regulating the amount of water in the water pool (30) subject to the amount of storage oil stored in the oil tank (40) for enabling water in the water pool (30) to support the oil tank (40) and storage oil in the oil tank (40) and to keep the oil tank (40) in balance by means of the physical characteristic that the specific gravity of the storage oil is lower than water.
Patent CA-2521706-A1 (CA)
Title: Secondary lithium battery module
Inventor: YU JI-SANG
IPC: H01M50/522
Filed: 2004-03-11
Abstract: Disclosed is a secondary lithium battery module. The secondary lithium battery module comprising a plurality of secondary lithium unit-batteries including anode and cathode terminals having a hole, which terminals are protruded in one direction in parallel to each other and alternately aligned; a receiving module having a plurality of non-metallic receiving unit-modules, each unit-module having recesses for receiving the anode and cathode terminals of the secondary lithium unit-batteries therein, each recess having a fixing hole; a metal block having a fixing hole and a contact plate and aligned in the recesses of the receiving unit-modules such that the metal block makes contact with at least one of the anode and cathode terminals of the secondary lithium unit-batteries accommodated in the recesses of the receiving unit-modules; a circuit board having a shape corresponding to a shape of the receiving module and aligned on an upper surface of the receiving module, the circuit board having recesses corresponding to the recesses of the receiving module and copper wirings formed at lateral portions of the recesses in order to make contact with the contact plate of the metal block; and a coupling member inserted into the recesses of the receiving module, the anode and cathode terminals of the secondary lithium unit-batteries accommodated in the recesses, and the fixing hole of the metal block making contact with at least one of the anode and cathode terminals so as to fixedly assemble the receiving module, secondary lithium unit-batteries and the metal block with each other.
Patent CA-2525201-A1 (CA)
Title: Plunger lift apparatus that includes one or more sensors
Inventor: SHEFFIELD RANDOLPH J
IPC: E21B47/12
Filed: 2005-11-02
Abstract: A plunger lift apparatus includes wellhead equipment containing a receiver, a conduit extending from the wellhead equipment into a wellbore, and a plunger to be run through the conduit to a downhole location in the wellbore. The plunger includes at least a sensor to measure a downhole parameter, and a plunger is adapted to communicate the measured downhole parameter to the receiver.
Patent CA-2527174-A1 (CA)
Title: Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor
Inventor: FLOHR ALEXANDER
IPC: A61P25/00
Filed: 2004-05-21
Abstract: Compounds of the general formula (I) and pharmaceutically acceptable acid addition salts thereof for the treatment of diseases, related to the A2A  receptor.
Patent CA-2529831-A1 (CA)
Inventor: KANOU YOSHINORI
IPC: B65D1/02
Filed: 2000-11-24
Abstract: A metal container with thread capable of preventing such a defect that t he strength of a lower end of a mouth part and an upper end of a shoulder part of a container main body is non-resistant to a pressing force in radial and axial direction s, and a part of the container may be collapsed or buckled during a capping operation wher e content is filled into the container and cap is fitted to the container automaticall y by a machine. The metal container is capable of maintaining a highly airtight condition by way of a curled or slightly rounded projection formed at the upper end of a mouth par t thereof which interacts with a packing laid on a ceiling surface of a cap which is screwed on.
Patent CA-2530385-A1 (CA)
Title: Melt extruded controlled release oxycodone multiparticulates
Inventor: HAYES GEOFFREY GERARD
IPC: A61K31/385
Filed: 2004-06-23
Abstract: Multipartulates of oxycodone can be made by extrusion of a blend which suitably contains (a) oxycodone, (b) water-insoluble ammonium methacrylate copolymer, (c) plasticiser, (d) lubricant and (e) water permeability modifier.
Patent CA-2530779-A1 (CA)
Inventor: BRIGGS ROBERT E
IPC: C07K14/285
Filed: 2004-07-02
Abstract: A capsular hyaE deletion mutants of P. multocida can be administered to mammals, particularly ungulates, or birds to provide protective immunity against wild-type P. multocida, e.g., to prevent or reduce the severity of hemorrhagic septicemia or pneumonia in mammals, particularly livestock, ungulates, and companion animals, or fowl cholera in birds, particularly poultry.